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The free-living amoeba Balamuthia mandrillaris is a rare but highly lethal agent of amoebic encephalitis in humans and many
other mammalian species. Here, we announce the first draft genome sequence of the original 1990 isolate cultured from the
brain of a deceased mandrill baboon.
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Balamuthia mandrillaris is an opportunistic parasite that causesamoebic encephalitis (BAE) in humans and other mammals
(1, 2), with a fatal outcome rate of 95%. The amoeba appears to
be ubiquitous in soil (3–5) and freshwater habitats (6), and it
invades its hosts via pulmonary (7), nasal/olfactory nerve (8), cu-
taneous (9), and possibly gastrointestinal (10) routes. BAE has
been reported in immunocompromised (11) patients and in chil-
dren and adults without clinical evidence for acquired or innate
immunodeficiency (12, 13). Experimental infections in mice lack-
ing lymphocyte subsets show that CD4 T cells are important for
resistance to intranasal B. mandrillaris infection and BAE (14).
Axenic cultivation of the CDC-V039 isolate was performed in
modified Chang’s special medium at 37°C in a humidified normal
atmosphere supplemented with 5% CO2 (15). Genomic DNA was
isolated with the Qiagen DNeasy blood and tissue kit, according to
the manufacturer’s instructions. Genome sequencing was per-
formed at the Robert Koch Institute on Roche 454 FLX, Illumina
HiScan, and Illumina HiSeq 1500 machines and on a Pacific Bio-
sciences RS II at the University of Lausanne (UNIL), Switzerland,
with 20, 1,600, and 90 read coverage, respectively. Genome
assembly of 756,805 PacBio reads with the HGAP3 (16) pipeline,
followed by quality filtering of contigs, resulted in a genome of 68
Mbp in 1,605 contigs, with an N50 value of 93,953 bp and an
average GC content of 46.8%. An integrated analysis using Illu-
mina, 454, and PacBio data revealed a complex genome with in-
dication of hyperploidy. A comparison of the mitochondrial ge-
nome structure and homology searches of Acanthamoeba
castellanii protein sequences in the newly assembled genome sug-
gest a more distant relationship of B. mandrillaris to its closest
known relative than was previously assumed. Functional genome
annotation is in progress and will help unravel the metabolic and
pathogenic potential of this opportunistic parasite.
Nucleotide sequence accession numbers. The draft genome
sequence of B. mandrillaris CDC-V039 has been deposited in Gen-
Bank under the accession no. LFUI00000000. The version de-
scribed in this paper is the first version, LFUI01000000.
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